LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
PACT
Prehospital Airway Control Trial : A Randomized Controlled Trial of Prehospital Airway Management Strategy for Trauma Patients
2 other identifiers
interventional
2,010
1 country
14
Brief Summary
The Prehospital Airway Control Trial (PACT) is a proposed 5 year, open label, multi-center, stepped-wedge randomized trial comparing airway management strategies of prehospital trauma patients. The initial airway attempt will be randomized to either usual care (control) or a supraglottic airway management approach (intervention). The primary outcome will be 24 hour survival, with secondary outcomes to include survival to hospital discharge, expected clinical adverse events, airway management performance, ICU length of stay, ventilator days, incidence of ARDS, and incidence of ventilator associated pneumonia. Subjects will be enrolled across approximately 17 prehospital agencies at select LITES Network sites and will enroll a total of 2,009 subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2019
CompletedFirst Posted
Study publicly available on registry
September 24, 2019
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2026
CompletedApril 14, 2026
April 1, 2026
4.9 years
September 11, 2019
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
24-hour survival
From injury through 24 hours
Secondary Outcomes (8)
Proportion of subjects that survive to hospital discharge
From hospital admission through death or hospital discharge up to 30 days
Rate of first pass success of placement of advanced airway device
At time of placement of device through confirmation of device placement
ICU length of stay
Admission through 30 days or discharge
Ventilator days
Admission through 30 days or discharge
Incidence of expected adverse events
From initial airway management through first 24 hours of hospital admission
- +3 more secondary outcomes
Study Arms (2)
Standard airway method arm
ACTIVE COMPARATORStandard airway management strategy
Supraglottic airway method arm
EXPERIMENTALSupraglottic first airway management strategy
Interventions
Initial advanced airway management with a supraglottic device
Initial advanced airway management with standard care method
Eligibility Criteria
You may qualify if:
- Traumatic injury requiring advanced airway management. Indicators of need for advanced airway management include: a) GCS\<8, b) SpO2\<90 despite supplemental oxygen, b) ETCO2\>60 despite supplemental ventilation, or d) provider discretion.
- Transport (or intended transport) to an enrolling LITES Trauma Center
You may not qualify if:
- \< 15 years of age
- Known pregnancy
- Known prisoner
- Initial advanced airway attempted by a non-PACT provider.
- Cardiac Arrest without return of spontaneous circulation (ROSC) at the time of the intervention
- Caustic substance ingestion
- Airway burns
- Objection to study voiced by subject or family member at the scene.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jason Sperrylead
- United States Department of Defensecollaborator
Study Sites (14)
Emory University
Atlanta, Georgia, 30303, United States
Mount Sinai Hospital
Chicago, Illinois, 60608, United States
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
John H. Stroger Hospital of Cook County
Chicago, Illinois, 60612, United States
University of Chicago
Chicago, Illinois, 60637, United States
University of Louisville
Louisville, Kentucky, 40208, United States
Tulane University
New Orleans, Louisiana, 70112, United States
Washington University at St. Louis
St Louis, Missouri, 63110, United States
East Carolina University
Greenville, North Carolina, 27835, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
UPMC
Pittsburgh, Pennsylvania, 15261, United States
Vanderbilt University
Nashville, Tennessee, 37235, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Sperry, MD, MPH
University of Pittsburgh
- PRINCIPAL INVESTIGATOR
Francis Guyette, MD, MPH
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 11, 2019
First Posted
September 24, 2019
Study Start
April 1, 2021
Primary Completion
March 7, 2026
Study Completion
April 7, 2026
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share